Stocks and Investing Stocks and Investing
Fri, July 21, 2023

Gena Wang Maintained (VIR) at Buy with Decreased Target to $41 on, Jul 21st, 2023


Published on 2024-10-28 05:01:11 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "Vir Biotechnology, Inc." (VIR) at Buy with Decreased Target from $59 to $41 on, Jul 21st, 2023.

Gena has made no other calls on VIR in the last 4 months.



There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 0 agree with Gena's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Gena


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $22 on, Thursday, July 20th, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $100 on, Thursday, July 20th, 2023

Contributing Sources